A probiotic, Lacticaseibacillus rhamnosus HA-114, was found to prevent neurodegeneration as a neuro protective agent in a C. elegans worm animal model. The research team is currently confirming their findings with similar tests of mice.

The December 20 2022 Neuroscience News report was conducted by Canada’s CHUM Research Center (CRCHUM) led by Université de Montréal neuroscience professor Alex Parker. Parker collaborated with Martine Tétreault and Matthieu Ruiz, researchers at the Montreal Heart Institute Research Center.

Parker and his team found that this probiotic disrupts lipid metabolism which contributes to cerebral and motor degeneration in ALS patients. He further explains that “gut microbiota is likely involved in the onset and progression of many incurable neurodegenerative diseases, including ALS” and Huntington’s disease, as quoted in the Neuroscience News article.

image source: dreamstime

More studies are being conducted today on mice based on this research using the C. elegans worm.

https://neurosciencenews.com/als-probiotics-22116/


Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: